Shopping Cart
- Remove All
Your shopping cart is currently empty
(R)-Lunresertib is the enantiomer of the PKMYT1 inhibitor RP-6306, which negatively regulates CDK1 via phosphorylation of threonine 14 and cytoplasmic sequestration. (R)-Lunresertib demonstrates single-agent antitumor efficacy in CCNE1-amplified xenograft models and shows synergistic effects with gemcitabine in CCNE1-amplified or overexpressing cell lines, providing a critical tool in cancer pharmacology and precision oncology research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $31 | 6-8 weeks | |
| 5 mg | $98 | 6-8 weeks | |
| 10 mg | $185 | 6-8 weeks | |
| 25 mg | $413 | 6-8 weeks | |
| 50 mg | $668 | 6-8 weeks | |
| 100 mg | $1,070 | 6-8 weeks | |
| 200 mg | $1,450 | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $68 | 6-8 weeks |
| Description | (R)-Lunresertib is the enantiomer of the PKMYT1 inhibitor RP-6306, which negatively regulates CDK1 via phosphorylation of threonine 14 and cytoplasmic sequestration. (R)-Lunresertib demonstrates single-agent antitumor efficacy in CCNE1-amplified xenograft models and shows synergistic effects with gemcitabine in CCNE1-amplified or overexpressing cell lines, providing a critical tool in cancer pharmacology and precision oncology research. |
| Targets&IC50 | PKMYT1:1360 nM |
| Synonyms | (R)-RP-6306, (R)-RP6306 |
| Molecular Weight | 324.38 |
| Formula | C18H20N4O2 |
| Cas No. | 2719793-91-4 |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (246.62 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.